| abstract |
An agent for treating eosinophilia, comprising a substance that induces eosinophil apoptosis via CD30 and / or a molecule involved in CD30 signal transduction as an active ingredient. The therapeutic agent is effective for allergic diseases, respiratory diseases, skin diseases, autoimmune diseases, immunodeficiency diseases, gastrointestinal diseases, neoplastic diseases and parasitic infectious diseases. |